US Patent

US10172874 — Pharmaceutical compositions comprising cyclic boronic acid ester derivatives

Formulation · Assigned to Rempex Pharmaceuticals Inc · Expires 2031-08-08 · 5y remaining

Vulnerability score 48/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects pharmaceutical compositions comprising cyclic boronic acid ester derivatives, which are used as therapeutic agents.

USPTO Abstract

Disclosed herein are antimicrobial compounds compositions, pharmaceutical compositions, the use and preparation thereof. Some embodiments relate to cyclic boronic acid ester derivatives and their use as therapeutic agents.

Drugs covered by this patent

Patent Metadata

Patent number
US10172874
Jurisdiction
US
Classification
Formulation
Expires
2031-08-08
Drug substance claim
No
Drug product claim
Yes
Assignee
Rempex Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.